198 related articles for article (PubMed ID: 27866926)
1. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.
Sarmiento E; Jaramillo M; Calahorra L; Fernandez-Yañez J; Gomez-Sanchez M; Crespo-Leiro MG; Paniagua M; Almenar L; Cebrian M; Rabago G; Levy B; Segovia J; Gomez-Bueno M; Lopez J; Mirabet S; Navarro J; Rodriguez-Molina JJ; Fernandez-Cruz E; Carbone J
J Heart Lung Transplant; 2017 May; 36(5):529-539. PubMed ID: 27866926
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: A multicenter prospective study.
Sarmiento E; Cifrian J; Calahorra L; Bravo C; Lopez S; Laporta R; Ussetti P; Sole A; Morales C; de Pablos A; Jaramillo M; Ezzahouri I; García S; Navarro J; Lopez-Hoyos M; Carbone J
J Heart Lung Transplant; 2018 Aug; 37(8):1001-1012. PubMed ID: 29754764
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an immunological score to assess the risk of severe infection in heart recipients.
Sarmiento E; Navarro J; Fernandez-Yañez J; Palomo J; Muñoz P; Carbone J
Transpl Infect Dis; 2014 Oct; 16(5):802-12. PubMed ID: 25179534
[TBL] [Abstract][Full Text] [Related]
4. Secondary antibody deficiency is associated with development of infection in kidney transplantation: Results of a multicenter study.
Sarmiento E; Jimenez M; di Natale M; Rodriguez-Ferrero M; Anaya F; Lopez-Hoyos M; Rodrigo E; Arias M; Perello M; Seron D; Karanovic B; Ezzahouri I; Mezzano S; Jaramillo M; Calahorra L; Alarcon A; Navarro J; Muñoz P; Carbone J
Transpl Infect Dis; 2021 Apr; 23(2):e13494. PubMed ID: 33064917
[TBL] [Abstract][Full Text] [Related]
5. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients.
Sarmiento E; del Pozo N; Gallego A; Fernández-Yañez J; Palomo J; Villa A; Ruiz M; Muñoz P; Rodríguez C; Rodríguez-Molina J; Navarro J; Kotsch K; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2012 Oct; 14(5):526-39. PubMed ID: 23013361
[TBL] [Abstract][Full Text] [Related]
7. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
[TBL] [Abstract][Full Text] [Related]
8. IgG monitoring to identify the risk for development of infection in heart transplant recipients.
Sarmiento E; Rodriguez-Molina JJ; Fernandez-Yañez J; Palomo J; Urrea R; Muñoz P; Bouza E; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2006 Mar; 8(1):49-53. PubMed ID: 16623821
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.
Carbone J; Micheloud D; Salcedo M; Rincon D; Bañares R; Clemente G; Jensen J; Sarmiento E; Rodriguez-Molina J; Fernandez-Cruz E
Transpl Infect Dis; 2008 Dec; 10(6):396-402. PubMed ID: 18657086
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
[TBL] [Abstract][Full Text] [Related]
11. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.
Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J
Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623
[TBL] [Abstract][Full Text] [Related]
12. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
[TBL] [Abstract][Full Text] [Related]
13. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and risk factors for late infection in solid organ transplant recipients.
Cervera C; Fernández-Ruiz M; Valledor A; Linares L; Antón A; Ángeles Marcos M; Sanclemente G; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Pumarola T; Moreno A
Transpl Infect Dis; 2011 Dec; 13(6):598-607. PubMed ID: 21535336
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection.
van Gent R; Metselaar HJ; Kwekkeboom J
Transplant Rev (Orlando); 2017 Apr; 31(2):78-86. PubMed ID: 28131494
[TBL] [Abstract][Full Text] [Related]
16. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.
San-Juan R; Navarro D; García-Reyne A; Montejo M; Muñoz P; Carratala J; Len O; Fortun J; Muñoz-Cobo B; Gimenez E; Eworo A; Sabe N; Meije Y; Martín-Davila P; Andres A; Delgado J; Jimenez C; Amat P; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Aguado JM;
Transpl Infect Dis; 2015 Oct; 17(5):637-46. PubMed ID: 26134282
[TBL] [Abstract][Full Text] [Related]
19. Hypogammaglobulinemia and risk of severe infection in kidney transplant recipients.
Augusto JF; Garnier AS; Demiselle J; Langs V; Picquet J; Legall R; Sargentini C; Culty T; Poli C; Ammi M; Ducancelle A; Chevailler A; Duveau A; Subra JF; Sayegh J
Transpl Infect Dis; 2016 Oct; 18(5):741-751. PubMed ID: 27509578
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients.
Gabardi S; Asipenko N; Fleming J; Lor K; McDevitt-Potter L; Mohammed A; Rogers C; Tichy EM; Weng R; Lee RA
Transplantation; 2015 Jul; 99(7):1499-505. PubMed ID: 25643140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]